Skip to main content

Table 2 Variables associated with metabolic syndrome

From: Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome

 

Univariate

Multivariatea

 

OR

95% CI

Pvalue

OR

95% CI

Pvalue

Body mass index

1.2

1.1-1.3

< 0.001

1.2

1.1-1.3

< 0.001

Pulse

1.03

1.01-1.06

0.011

1.03

1.00-1.06

0.020

Creatinine

1.01

1.00-1.02

0.080

1.02

1.00-1.03

0.017

Hypothyroidism

4.5

1.5-13.2

0.007

4.7

1.5-15.0

0.009

Diabetes mellitus

4.8

1.8-12.9

0.002

4.5

1.4-15.2

0.014

  1. aIn multivariate analyses, the following variables were used: gender, age, prednisolone only, methotrexate only, sulfasalazine only, hydroxychloroquine only, tumour necrosis factor-blocking agents, combination of disease-modifying antirheumatic drugs, pack-years, smoking, erosions, DAS28 (disease activity score using 28 joint counts), body mass index, pulse rate, creatinine levels, renal clearance, hypothyroidism and diabetes mellitus. CI, confidence interval; OR, odds ratio.